Literature DB >> 11944865

Imaging the microcirculation of untreated and treated human choroidal melanomas.

A J Mueller1, D U Bartsch, U Schaller, W R Freeman, A Kampik.   

Abstract

INTRODUCTION: Histologically demonstrable microcirculation patterns (microcirculation pattern) of human choroidal melanomas have prognostic significance for the patient. We report on our experience in imaging these microcirculation pattern in vivo using simultaneous confocal Fluorescein (FA)- and Indocyaninegreen (ICG) angiography before and after brachytherapy. PATIENTS AND METHODS: The simultaneously procured confocal FA- and ICG angiograms of 50 patients with untreated choroidal melanomas were studied for the visibility of microcirculation pattern. Patients were also followed with simultaneous FA/ICG after brachytherapy.
RESULTS: Confocal FA disclosed signs of tumor vascularization in 12 (24%) of the 50 examined patients but microcirculation pattern only in 3 patients (6%). In contrast, simultaneously obtained confocal ICG disclosed microcirculation pattern in 47 patients (94%). In 10 (77%) of the 13 patients the tumor microcirculation changed considerably after brachytherapy: Distortion, thickening, thinning, as well as complete obliteration of vessels could be observed.
CONCLUSION: Histologically demonstrated microcirculation pattern can be imaged in vivo. This offers the possibility to assess the likely biologic behavior of the individual tumor without the need for obtaining a cytologic or histologic specimen via enucleation or fine-needle biopsy. Confocal ICG angiogiography images microcirculation pattern better than FA which can be explained by the different absorption-, fluorescence- and exudation-characteristics ICG. Follow-up with confocal ICG of choroidal melanomas after brachytherapy shows different features and allows for visualization of the microcirculation reaction to the treatment which might be a useful tool for studying the effects of future anti-angiogenesis based tumor therapies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11944865     DOI: 10.1023/a:1014471118208

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  34 in total

Review 1.  Factors controlling ocular angiogenesis.

Authors:  R Casey; W W Li
Journal:  Am J Ophthalmol       Date:  1997-10       Impact factor: 5.258

2.  A histopathologic fluorescein angiographic correlative study of malignant melanomas of the choroid.

Authors:  R J Flindall; J D Gass
Journal:  Can J Ophthalmol       Date:  1971-10       Impact factor: 1.882

3.  Angiography of the retina with indocyanine green.

Authors:  B F Hochheimer
Journal:  Arch Ophthalmol       Date:  1971-11

4.  Confocal scanning infrared laser ophthalmoscopy for indocyanine green angiography.

Authors:  D U Bartsch; R N Weinreb; G Zinser; W R Freeman
Journal:  Am J Ophthalmol       Date:  1995-11       Impact factor: 5.258

5.  Injection technique for indocyanine green and sodium fluorescein dye angiography of the eye.

Authors:  R W Flower
Journal:  Invest Ophthalmol       Date:  1973-12

6.  Accuracy of diagnosis of choroidal melanomas in the Collaborative Ocular Melanoma Study. COMS report no. 1.

Authors: 
Journal:  Arch Ophthalmol       Date:  1990-09

7.  Histopathology of uveal melanomas treated with charged particle radiation.

Authors:  J B Crawford; D H Char
Journal:  Ophthalmology       Date:  1987-06       Impact factor: 12.079

8.  Ten years experience with choroidal angiography using indocyanine green dye: a new routine examination or an epilogue?

Authors:  P M Bischoff; R W Flower
Journal:  Doc Ophthalmol       Date:  1985-09-30       Impact factor: 2.379

9.  Fluorescein angiography in the long-term follow-up of choroidal melanoma after conservative treatment.

Authors:  A Tarkkanen; L Laatikainen
Journal:  Acta Ophthalmol (Copenh)       Date:  1985-02

10.  Phase II trial of carbetimer in metastatic melanoma.

Authors:  W D Quan; M S Mitchell
Journal:  Invest New Drugs       Date:  1993 May-Aug       Impact factor: 3.850

View more
  6 in total

1.  Involvement of circulatory disturbance in optic disk melanocytoma with visual dysfunction.

Authors:  Iku Kikuchi; Satoru Kase; Yuki Hashimoto; Kiriko Hirooka; Susumu Ishida
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-02-04       Impact factor: 3.117

2.  "Melanoma inhibitory activity" (MIA): a promising serological tumour marker in metastatic uveal melanoma.

Authors:  I W Reiniger; U C Schaller; C Haritoglou; R Hein; A K Bosserhoff; A Kampik; A J Mueller
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-05-20       Impact factor: 3.117

3.  Orthotopic human choroidal melanoma xenografts in nude rats with aggressive and nonaggressive PAS staining patterns.

Authors:  Rod D Braun; Asad Abbas
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-01       Impact factor: 4.799

4.  Vascular perfusion of choroidal melanoma by 3.0 tesla magnetic resonance imaging.

Authors:  Bruce M Buerk; Jose S Pulido; Ignacio Chiong; Robert Folberg; Deepak P Edward; Mark T Duffy; Keith R Thulborn
Journal:  Trans Am Ophthalmol Soc       Date:  2004

5.  Post-brachytherapy initial tumour regression rate correlates with metastatic spread in posterior uveal melanoma.

Authors:  I Kaiserman; I Anteby; I Chowers; E Z Blumenthal; I Kliers; J Pe'er
Journal:  Br J Ophthalmol       Date:  2004-07       Impact factor: 4.638

Review 6.  Molecular design of upconversion nanoparticles for gene delivery.

Authors:  Wing-Fu Lai; Andrey L Rogach; Wing-Tak Wong
Journal:  Chem Sci       Date:  2017-08-29       Impact factor: 9.825

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.